Why the study?
Many characteristics of PLN R14del cardiomyopathy remain unclear, including phenotypic triggers, disease progression, and disease-specific biomarkers.
Population
101 participants, including 91 PLN R14del carriers and 10 with HF of another aetiology
Comparison
Unaffected vs early affected vs end-stage PLN R14del carriers vs HF of another aetiology
Design
Cohort study rationale, design, and baseline characteristics
Authors
Loading...
New PLN R14del cohort spans disease spectrum; leaves open triggers, progression, and biomarkers for future study.
Key points are not available for this paper at this time.
Deiman et al. (2025) studied this question.